Bioengineered protein-based nanocage for drug delivery.
暂无分享,去创建一个
[1] John E. Johnson,et al. The role of subunit hinges and molecular "switches" in the control of viral capsid polymorphism. , 2006, Journal of structural biology.
[2] J. Champion,et al. Protein nanoparticles for therapeutic protein delivery. , 2015, Biomaterials science.
[3] So Jin Lee,et al. Engineered Proteinticles for Targeted Delivery of siRNA to Cancer Cells , 2015 .
[4] J. Hess,et al. Efficient Intracellular Delivery of a Protein and a Low Molecular Weight Substance via Recombinant Polyomavirus-like Particles* , 2004, Journal of Biological Chemistry.
[5] M. Finn,et al. Cell Targeting with Hybrid Qβ Virus‐Like Particles Displaying Epidermal Growth Factor , 2011, Chembiochem : a European journal of chemical biology.
[6] Chin-Tarng Lin,et al. Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery , 2008, Molecular Cancer Therapeutics.
[7] Hongwei Shang,et al. A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection , 2011, Influenza research and treatment.
[8] M. Hashizume,et al. Biological evaluation of protein nanocapsules containing doxorubicin , 2013, International journal of nanomedicine.
[9] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[10] J. E. Mealy,et al. Interior engineering of a viral nanoparticle and its tumor homing properties. , 2012, Biomacromolecules.
[11] David J Brayden,et al. Controlled release technologies for drug delivery. , 2003, Drug discovery today.
[12] Jun Wang,et al. Protein-based nanomedicine platforms for drug delivery. , 2009, Small.
[13] Duane E. Prasuhn,et al. Plasma clearance of bacteriophage Qbeta particles as a function of surface charge. , 2008, Journal of the American Chemical Society.
[14] Allie C. Obermeyer,et al. Oxidative modification of native protein residues using cerium(IV) ammonium nitrate. , 2011, Journal of the American Chemical Society.
[15] K. Schwarz,et al. Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects , 2004, The Journal of Immunology.
[16] W. Brown,et al. Delivery of antisense oligonucleotides to leukemia cells by RNA bacteriophage capsids. , 2005, Nanomedicine : nanotechnology, biology, and medicine.
[17] Mark B. Carter,et al. Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles. , 2011, ACS nano.
[18] Jean-Pierre Andrieu,et al. Adenovirus Dodecahedron, as a Drug Delivery Vector , 2009, PloS one.
[19] J. Whittle,et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies , 2013, Nature.
[20] P. Prevelige,et al. Virus-like particle nanoreactors: programmed encapsulation of the thermostable CelB glycosidase inside the P22 capsid , 2012 .
[21] N. Steinmetz,et al. Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: cargo-loading and delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[22] D. Baker,et al. Computational Design of Self-Assembling Protein Nanomaterials with Atomic Level Accuracy , 2012, Science.
[23] N. Elad,et al. Improved Doxorubicin Encapsulation and Pharmacokinetics of Ferritin-Fusion Protein Nanocarriers Bearing Proline, Serine, and Alanine Elements. , 2016, Biomacromolecules.
[24] Greg L. Hura,et al. Structure of a Designed Protein Cage that Self-Assembles into a Highly Porous Cube , 2014, Nature chemistry.
[25] R. Nolte,et al. Natural supramolecular protein assemblies. , 2016, Chemical Society reviews.
[26] Yu-Ying He,et al. Pristine (C60) and hydroxylated [C60(OH)24] fullerene phototoxicity towards HaCaT keratinocytes: type I vs type II mechanisms. , 2008, Chemical Research in Toxicology.
[27] Sang J. Chung,et al. Developing an antibody-binding protein cage as a molecular recognition drug modular nanoplatform. , 2012, Biomaterials.
[28] Youyu Zhang,et al. Apoferritin-based nanomedicine platform for drug delivery: equilibrium binding study of daunomycin with DNA , 2011 .
[29] M. McConnell,et al. Protein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesions. , 2011, ACS nano.
[30] Derek N. Woolfson,et al. More than just bare scaffolds: towards multi-component and decorated fibrous biomaterials. , 2010, Chemical Society reviews.
[31] Andrew K. Udit,et al. Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds. , 2010, Chemistry & biology.
[32] M. Hashizume,et al. Design and Function of Engineered Protein Nanocages as a Drug Delivery System for Targeting Pancreatic Cancer Cells via Neuropilin-1. , 2015, Molecular pharmaceutics.
[33] J. Szostak,et al. In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.
[34] Kwangmeyung Kim,et al. Systemic delivery of siRNA by chimeric capsid protein: tumor targeting and RNAi activity in vivo. , 2013, Molecular pharmaceutics.
[35] M. Young,et al. A click chemistry based coordination polymer inside small heat shock protein. , 2010, Chemical communications.
[36] M. Francis,et al. Oxidative coupling of peptides to a virus capsid containing unnatural amino acids. , 2008, Chemical communications.
[37] Trevor Douglas,et al. Host–guest encapsulation of materials by assembled virus protein cages , 1998, Nature.
[38] Kedar G. Patel,et al. Surface functionalization of virus-like particles by direct conjugation using azide-alkyne click chemistry. , 2011, Bioconjugate chemistry.
[39] J. Bale,et al. Structure of a designed tetrahedral protein assembly variant engineered to have improved soluble expression , 2015, Protein science : a publication of the Protein Society.
[40] N. Stephanopoulos,et al. Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells. , 2010, ACS nano.
[41] S. Müller,et al. Optimizing the refolding conditions of self-assembling polypeptide nanoparticles that serve as repetitive antigen display systems , 2011, Journal of Structural Biology.
[42] V. Kickhoefer,et al. Targeted vault nanoparticles engineered with an endosomolytic peptide deliver biomolecules to the cytoplasm. , 2011, ACS nano.
[43] Upendra K. Kar,et al. Vault Nanocapsules as Adjuvants Favor Cell-Mediated over Antibody-Mediated Immune Responses following Immunization of Mice , 2012, PloS one.
[44] U. Sleytr,et al. A Novel Approach to Specific Allergy Treatment: The Recombinant Allergen-S-Layer Fusion Protein rSbsC-Bet v 1 Matures Dendritic Cells That Prime Th0/Th1 and IL-10-Producing Regulatory T Cells1 , 2007, The Journal of Immunology.
[45] P. Prevelige,et al. Implementation of p22 viral capsids as nanoplatforms. , 2010, Biomacromolecules.
[46] V. Kickhoefer,et al. Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP. , 2004, Journal of molecular biology.
[47] Yuehe Lin,et al. Hyaluronic acid-conjugated apoferritin nanocages for lung cancer targeted drug delivery. , 2015, Biomaterials science.
[48] T. Daniels,et al. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. , 2006, Clinical immunology.
[49] Hongzhe Sun,et al. Encapsulation of platinum anticancer drugs by apoferritin. , 2007, Chemical communications.
[50] John E. Johnson,et al. Heterologous expression of the modified coat protein of Cowpea chlorotic mottle bromovirus results in the assembly of protein cages with altered architectures and function. , 2004, The Journal of general virology.
[51] V. Kickhoefer,et al. Targeting vault nanoparticles to specific cell surface receptors. , 2009, ACS nano.
[52] Inge J. Minten,et al. Virus-like particles templated by DNA micelles: a general method for loading virus nanocarriers. , 2010, Journal of the American Chemical Society.
[53] John E. Johnson,et al. Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus. , 2003 .
[54] E. Nelson,et al. Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation. , 2013, ACS nano.
[55] Derek N. Woolfson,et al. More than Just Bare Scaffolds: Towards Multi-Component and Decorated Fibrous Biomaterials , 2010 .
[56] Y. Do,et al. Lumazine synthase protein cage nanoparticles as antigen delivery nanoplatforms for dendritic cell-based vaccine development , 2014, Clinical and experimental vaccine research.
[57] Zhijun Zhang,et al. Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery. , 2011, Bioconjugate chemistry.
[58] B. Cargile,et al. Identification of bacteriophage MS2 coat protein from E. coli lysates via ion trap collisional activation of intact protein ions. , 2001, Analytical chemistry.
[59] John E. Johnson,et al. Natural supramolecular building blocks. Wild-type cowpea mosaic virus. , 2002, Chemistry & biology.
[60] Mihee M. Kim,et al. pH-dependent structures of ferritin and apoferritin in solution: disassembly and reassembly. , 2011, Biomacromolecules.
[61] M. Young,et al. Targeting and photodynamic killing of a microbial pathogen using protein cage architectures functionalized with a photosensitizer. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[62] T. Douglas,et al. Iron and cobalt oxide and metallic nanoparticles prepared from ferritin. , 2004, Langmuir : the ACS journal of surfaces and colloids.
[63] P. Pumpens,et al. Mosaic Qβ coats as a new presentation model , 1998 .
[64] In‐San Kim,et al. Chimeric capsid protein as a nanocarrier for siRNA delivery: stability and cellular uptake of encapsulated siRNA. , 2011, ACS nano.
[65] S. Schmid,et al. Multivalent Display and Receptor‐Mediated Endocytosis of Transferrin on Virus‐Like Particles , 2010, Chembiochem : a European journal of chemical biology.
[66] Shuguang Zhang. Fabrication of novel biomaterials through molecular self-assembly , 2003, Nature Biotechnology.
[67] Jiansheng Liang,et al. Cucumber mosaic virus as drug delivery vehicle for doxorubicin. , 2013, Biomaterials.
[68] M. Hashizume,et al. Development of human hepatocellular carcinoma cell-targeted protein cages. , 2012, Bioconjugate chemistry.
[69] Fan Zhang,et al. Chimeric ferritin nanocages for multiple function loading and multimodal imaging. , 2011, Nano letters.
[70] Stephan Wilkens,et al. Deletion of Highly Conserved Arginine-Rich RNA Binding Motif in Cowpea Chlorotic Mottle Virus Capsid Protein Results in Virion Structural Alterations and RNA Packaging Constraints , 2005, Journal of Virology.
[71] Qin Guo,et al. Protective Antibody and CD8+ T-Cell Responses to the Plasmodium falciparum Circumsporozoite Protein Induced by a Nanoparticle Vaccine , 2012, PloS one.
[72] Jacob M Hooker,et al. Interior surface modification of bacteriophage MS2. , 2004, Journal of the American Chemical Society.
[73] M. Santoro,et al. Heat shock factors and the control of the stress response. , 2000, Biochemical pharmacology.
[74] E. Chiancone,et al. Thermal stability of horse spleen apoferritin and human recombinant H apoferritin. , 1996, Archives of biochemistry and biophysics.
[75] V. Kickhoefer,et al. Bioengineered Vaults: Self-Assembling Protein Shell–Lipophilic Core Nanoparticles for Drug Delivery , 2014, ACS nano.
[76] O. Benada,et al. Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles , 2012, International journal of nanomedicine.
[77] V. Kickhoefer,et al. Vaults engineered for hydrophobic drug delivery. , 2011, Small.
[78] S. Raman,et al. Nanoscale assemblies and their biomedical applications , 2013, Journal of The Royal Society Interface.
[79] Wei Wang,et al. Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell-penetrating peptide. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[80] P. Prevelige,et al. Use of the interior cavity of the P22 capsid for site-specific initiation of atom-transfer radical polymerization with high-density cargo loading. , 2012, Nature chemistry.
[81] M. Finn,et al. Virus-glycopolymer conjugates by copper(I) catalysis of atom transfer radical polymerization and azide-alkyne cycloaddition. , 2005, Chemical communications.
[82] D. Ho,et al. CD40L-Containing Virus-Like Particle as a Candidate HIV-1 Vaccine Targeting Dendritic Cells , 2011, Journal of acquired immune deficiency syndromes.
[83] B. Wiedenheft,et al. Programmed Self-Assembly of an Active P22-Cas9 Nanocarrier System. , 2016, Molecular pharmaceutics.
[84] K. Nagayama,et al. Permeation of small molecules into the cavity of ferritin as revealed by proton nuclear magnetic resonance relaxation. , 1995, The Biochemical journal.
[85] Trevor Douglas,et al. Viruses: Making Friends with Old Foes , 2006, Science.
[86] Donald Hilvert,et al. Directed Evolution of a Protein Container , 2011, Science.
[87] N. Steinmetz,et al. Development of viral nanoparticles for efficient intracellular delivery. , 2012, Nanoscale.
[88] Q. Wang,et al. Icosahedral Virus Particles as Polyvalent Carbohydrate Display Platforms , 2003, Chembiochem : a European journal of chemical biology.
[89] P. Prevelige,et al. Genetically programmed in vivo packaging of protein cargo and its controlled release from bacteriophage P22. , 2011, Angewandte Chemie.
[90] Qian Wang,et al. Adaptations of nanoscale viruses and other protein cages for medical applications. , 2006, Nanomedicine : nanotechnology, biology, and medicine.
[91] S. Kim,et al. Lumazine synthase protein cage nanoparticles as modular delivery platforms for targeted drug delivery , 2014 .
[92] M. Morris,et al. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics , 2009, British journal of pharmacology.
[93] H. Pasolli,et al. Virus-Like Particles Harboring CCL19, IL-2 and HPV16 E7 Elicit Protective T Cell Responses in HLA-A2 Transgenic Mice , 2012, The open virology journal.
[94] S. Howorka. Rationally engineering natural protein assemblies in nanobiotechnology. , 2011, Current opinion in biotechnology.
[95] David Baker,et al. Accurate design of co-assembling multi-component protein nanomaterials , 2014, Nature.
[96] D. Clark,et al. Solubilization and stabilization of bacteriophage MS2 in organic solvents , 2007, Biotechnology and bioengineering.
[97] John E. Johnson,et al. Potato virus X as a novel platform for potential biomedical applications. , 2010, Nano letters.
[98] Gustavo Helguera,et al. The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. , 2006, Clinical immunology.
[99] G. Lomonossoff,et al. Cowpea mosaic virus-based chimaeras. Effects of inserted peptides on the phenotype, host range, and transmissibility of the modified viruses. , 2003, Virology.
[100] Dongmei Ren,et al. Protein nanocapsules containing doxorubicin as a pH-responsive delivery system. , 2011, Small.
[101] In‐San Kim,et al. A Double‐Chambered Protein Nanocage Loaded with Thrombin Receptor Agonist Peptide (TRAP) and γ‐Carboxyglutamic Acid of Protein C (PC‐Gla) for Sepsis Treatment , 2015, Advanced materials.
[102] R. Naik,et al. Engineered protein cages for nanomaterial synthesis. , 2004, Journal of the American Chemical Society.
[103] Rui Zhang,et al. MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice , 2012, International journal of nanomedicine.
[104] John A. Robinson,et al. Synthetic virus-like particles from self-assembling coiled-coil lipopeptides and their use in antigen display to the immune system. , 2007, Angewandte Chemie.
[105] N. Steinmetz,et al. Cowpea mosaic virus for material fabrication: addressable carboxylate groups on a programmable nanoscaffold. , 2006, Langmuir : the ACS journal of surfaces and colloids.
[106] S. Raman,et al. Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles. , 2006, Nanomedicine : nanotechnology, biology, and medicine.
[107] Trevor Douglas,et al. A streptavidin-protein cage Janus particle for polarized targeting and modular functionalization. , 2009, Journal of the American Chemical Society.
[108] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[109] V. Kickhoefer,et al. A Vault Nanoparticle Vaccine Induces Protective Mucosal Immunity , 2009, PloS one.
[110] M. Hashizume,et al. A nanocarrier based on a genetically engineered protein cage to deliver doxorubicin to human hepatocellular carcinoma cells. , 2013, Chemical communications.
[111] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[112] Corwin M. Nycholat,et al. Colorful virus-like particles: fluorescent protein packaging by the Qβ capsid. , 2011, Biomacromolecules.
[113] Rajesh R Naik,et al. Protein- and peptide-directed syntheses of inorganic materials. , 2008, Chemical reviews.
[114] M. Young,et al. Chemical modification of a viral cage for multivalent presentation. , 2002, Chemical communications.
[115] J. Chang,et al. In vitro and in vivo targeted delivery of IL-10 interfering RNA by JC virus-like particles , 2010, Journal of Biomedical Science.
[116] Arlo Z. Randall,et al. Biomimetic Design of Protein Nanomaterials for Hydrophobic Molecular Transport , 2012, Advanced functional materials.
[117] Duane E. Prasuhn,et al. Unnatural amino acid incorporation into virus-like particles. , 2008, Bioconjugate chemistry.
[118] B. Schwarz,et al. Development of virus-like particles for diagnostic and prophylactic biomedical applications. , 2015, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[119] Sonny C. Hsiao,et al. Viral capsid DNA aptamer conjugates as multivalent cell-targeting vehicles. , 2009, Journal of the American Chemical Society.
[120] M. Finn,et al. Accelerated bioorthogonal conjugation: a practical method for the ligation of diverse functional molecules to a polyvalent virus scaffold. , 2005, Bioconjugate chemistry.
[121] Yuguang Du,et al. Bio-inspired protein-gold nanoconstruct with core-void-shell structure: beyond a chemo drug carrier. , 2013, Journal of materials chemistry. B.
[122] P. Pumpens,et al. RNA Phage Qβ Coat Protein as a Carrier for Foreign Epitopes , 1996 .
[123] Satish K. Nune,et al. Nanoparticles for biomedical imaging , 2009, Expert opinion on drug delivery.
[124] S. Achilefu,et al. A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy. , 2012, Biomaterials.
[125] M. Young,et al. Selective attachment and release of a chemotherapeutic agent from the interior of a protein cage architecture. , 2005, Chemical communications.
[126] P. Prevelige,et al. Coconfinement of fluorescent proteins: spatially enforced communication of GFP and mCherry encapsulated within the P22 capsid. , 2012, Biomacromolecules.
[127] V. Marchesi,et al. Chemical characterization and surface orientation of the major glycoprotein of the human erythrocyte membrane. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[128] Inge J. Minten,et al. Controlled encapsulation of multiple proteins in virus capsids. , 2009, Journal of the American Chemical Society.
[129] Lars Liljas,et al. The three-dimensional structure of the bacterial virus MS2 , 1990, Nature.
[130] P. Prevelige,et al. P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents. , 2013, Molecular pharmaceutics.
[131] Philip S Low,et al. Folate-mediated delivery of macromolecular anticancer therapeutic agents. , 2002, Advanced drug delivery reviews.
[132] Tian Xia,et al. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. , 2011, ACS nano.
[133] Horst Kessler,et al. Guiding plant virus particles to integrin-displaying cells. , 2012, Nanoscale.
[134] T. Gedeon,et al. Encapsulation of an enzyme cascade within the bacteriophage P22 virus-like particle. , 2014, ACS chemical biology.
[135] N. Steinmetz,et al. PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivo. , 2009, Biomacromolecules.
[136] M. Bellini,et al. Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[137] A. Rynda-Apple,et al. Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza. , 2013, ACS nano.
[138] P. Couvreur,et al. A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles , 2005, Cellular and Molecular Life Sciences.
[139] P. Burkhard,et al. Conformation‐specific Display of 4E10 and 2F5 Epitopes on Self‐assembling Protein Nanoparticles as a Potential HIV Vaccine , 2012, Chemical biology & drug design.
[140] A. Bleloch,et al. 3D morphology of the human hepatic ferritin mineral core: New evidence for a subunit structure revealed by single particle analysis of HAADF-STEM images , 2009, Journal of structural biology.
[141] Serdar Kuyucak,et al. Functional properties of threefold and fourfold channels in ferritin deduced from electrostatic calculations. , 2003, Biophysical journal.
[142] H. Maeda,et al. Carbon monoxide, generated by heme oxygenase‐1, mediates the enhanced permeability and retention effect in solid tumors , 2012, Cancer science.
[143] V. Kickhoefer,et al. Assembly of Vault-like Particles in Insect Cells Expressing Only the Major Vault Protein* , 2001, The Journal of Biological Chemistry.
[144] John E. Johnson,et al. Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus. , 2003, Biomacromolecules.
[145] M. Young,et al. Targeted Delivery of a Photosensitizer to Aggregatibacter actinomycetemcomitans Biofilm , 2010, Antimicrobial Agents and Chemotherapy.
[146] John E. Johnson,et al. Generation and structural analysis of reactive empty particles derived from an icosahedral virus. , 2006, Chemistry & biology.
[147] Warren C W Chan,et al. The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.
[148] P. Burkhard,et al. Coiled coils: a highly versatile protein folding motif. , 2001, Trends in cell biology.
[149] B. Gallois,et al. Crystal structure and biochemical properties of the human mitochondrial ferritin and its mutant Ser144Ala. , 2004, Journal of molecular biology.
[150] V. Kickhoefer,et al. Structural stability of vault particles. , 2009, Journal of pharmaceutical sciences.
[151] M. Young,et al. Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. , 2006, Journal of the American Chemical Society.
[152] S. Zhang,et al. Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV. , 2010, Vaccine.
[153] W. Berger,et al. Vaults and the major vault protein: Novel roles in signal pathway regulation and immunity , 2008, Cellular and Molecular Life Sciences.
[154] L. Liljas,et al. Crystallization and preliminary X-ray diffraction studies of the bacteriophage Qbeta. , 1994, Acta crystallographica. Section D, Biological crystallography.
[155] M. Young,et al. Supramolecular protein cage composite MR contrast agents with extremely efficient relaxivity properties. , 2009, Nano letters.
[156] J. Paulson,et al. On-virus construction of polyvalent glycan ligands for cell-surface receptors. , 2008, Journal of the American Chemical Society.
[157] Vault nanocapsule dissociation into halves triggered at low pH. , 2007, Biochemistry.
[158] Stephen H. Hughes,et al. Protein delivery using engineered virus-like particles , 2011, Proceedings of the National Academy of Sciences.
[159] M. Hashizume,et al. Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocages , 2012, International journal of nanomedicine.
[160] Jan C M van Hest,et al. Functionalization of protein-based nanocages for drug delivery applications. , 2014, Nanoscale.
[161] Corwin M. Nycholat,et al. Glycan-targeted virus-like nanoparticles for photodynamic therapy. , 2012, Biomacromolecules.
[162] Hyun-Jae Shin,et al. Viruses as self-assembled nanocontainers for encapsulation of functional cargoes , 2013, Korean Journal of Chemical Engineering.
[163] R. Hodges,et al. Peptide Nanoparticles as Novel Immunogens: Design and Analysis of a Prototypic Severe Acute Respiratory Syndrome Vaccine , 2008, Chemical biology & drug design.
[164] Allie C. Obermeyer,et al. Rapid chemoselective bioconjugation through oxidative coupling of anilines and aminophenols. , 2011, Journal of the American Chemical Society.
[165] D. Hilvert,et al. A simple tagging system for protein encapsulation. , 2006, Journal of the American Chemical Society.
[166] Y. Sun,et al. Small heat shock proteins: molecular structure and chaperone function , 2005, Cellular and Molecular Life Sciences CMLS.
[167] N. Steinmetz,et al. Buckyballs meet viral nanoparticles: candidates for biomedicine. , 2009, Journal of the American Chemical Society.
[168] R. Gref,et al. Synthetic and bioinspired cage nanoparticles for drug delivery. , 2014, Nanomedicine.
[169] R. Dummer,et al. Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+ T-cell responses in melanoma patients , 2012, European journal of immunology.
[170] K. Breitenkamp,et al. Functional virus-based polymer-protein nanoparticles by atom transfer radical polymerization. , 2011, Journal of the American Chemical Society.
[171] V. Kickhoefer,et al. Vault nanoparticles containing an adenovirus-derived membrane lytic protein facilitate toxin and gene transfer. , 2009, ACS nano.
[172] D. A. Kharkevich,et al. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. , 1998, Journal of microencapsulation.
[173] Jin Xie,et al. RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors. , 2013, ACS nano.
[174] M. Bova,et al. Subunit Exchange, Conformational Stability, and Chaperone-like Function of the Small Heat Shock Protein 16.5 fromMethanococcus jannaschii * , 2002, The Journal of Biological Chemistry.
[175] A. Vahrmeijer,et al. Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer , 2012, Journal of surgical oncology.
[176] John E. Johnson,et al. Natural supramolecular building blocks. Cysteine-added mutants of cowpea mosaic virus. , 2002, Chemistry & biology.
[177] Trevor Douglas,et al. The Small Heat Shock Protein Cage from Methanococcus jannaschii Is a Versatile Nanoscale Platform for Genetic and Chemical Modification , 2003 .
[178] A. Rynda-Apple,et al. A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose , 2012, Vaccine.
[179] J. Fiedler,et al. Assembly of hybrid bacteriophage Qbeta virus-like particles. , 2009, Biochemistry.
[180] Derek N. Woolfson,et al. Engineering nanoscale order into a designed protein fiber , 2007, Proceedings of the National Academy of Sciences.
[181] Kwangmeyung Kim,et al. Proteinticle/Gold Core/Shell Nanoparticles for Targeted Cancer Therapy without Nanotoxicity , 2014, Advanced materials.
[182] D. Woolfson,et al. Peptide and protein based materials in 2010: from design and structure to function and application. , 2010, Chemical Society reviews.
[183] N. Steinmetz,et al. Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting. , 2010, Nano letters.
[184] Sung-Hou Kim,et al. Crystal structure of a small heat-shock protein , 1998, Nature.
[185] M. Finn,et al. Blue fluorescent antibodies as reporters of steric accessibility in virus conjugates. , 2003, Bioconjugate chemistry.
[186] G. Whitesides. The 'right' size in nanobiotechnology , 2003, Nature Biotechnology.
[187] A. Lascialfari,et al. MRI relaxation properties of water-soluble apoferritin-encapsulated gadolinium oxide-hydroxide nanoparticles. , 2009, Dalton transactions.
[188] Sebyung Kang,et al. Developing genetically engineered encapsulin protein cage nanoparticles as a targeted delivery nanoplatform. , 2014, Biomacromolecules.
[189] Marianne Manchester,et al. Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells. , 2007, Chemistry & biology.
[190] N. Steinmetz,et al. Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle Potato virus X. , 2013, Molecular pharmaceutics.
[191] M. Manchester,et al. Biomedical nanotechnology using virus-based nanoparticles. , 2009, Current topics in microbiology and immunology.
[192] Hoai Viet Nguyen,et al. Apoferritin Modified Magnetic Particles as Doxorubicin Carriers for Anticancer Drug Delivery , 2013, International journal of molecular sciences.
[193] U. Aebi,et al. The biodistribution of self-assembling protein nanoparticles shows they are promising vaccine platforms , 2013, Journal of Nanobiotechnology.
[194] Zhi-ping Zhang,et al. Multifunctional ferritin cage nanostructures for fluorescence and MR imaging of tumor cells. , 2012, Nanoscale.
[195] Y. Tong,et al. Self-assembly of collagen-mimetic peptide amphiphiles into biofunctional nanofiber. , 2011, ACS nano.
[196] Sung You Hong,et al. Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[197] Zakir Hossain,et al. Prospects and applications of nanobiotechnology: a medical perspective , 2012, Journal of Nanobiotechnology.
[198] M. Young,et al. Controlled ligand display on a symmetrical protein-cage architecture through mixed assembly. , 2006, Small.
[199] In‐San Kim,et al. Designed nanocage displaying ligand-specific Peptide bunches for high affinity and biological activity. , 2013, ACS nano.
[200] Dongling Yang,et al. H-ferritin–nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection , 2014, Proceedings of the National Academy of Sciences.
[201] Duilio Cascio,et al. Structure of a 16-nm Cage Designed by Using Protein Oligomers , 2012, Science.
[202] Sek-Man Wong,et al. Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin. , 2007, Bioconjugate chemistry.
[203] M. Kinjo,et al. Virus-like particles with removable cyclodextrins enable glutathione-triggered drug release in cells. , 2013, Molecular bioSystems.
[204] A. Heck,et al. Encapsulation of phthalocyanine supramolecular stacks into virus-like particles. , 2011, Journal of the American Chemical Society.
[205] Jennifer E. Padilla,et al. Nanohedra: Using symmetry to design self assembling protein cages, layers, crystals, and filaments , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[206] J. Hainfeld,et al. Uranium-loaded apoferritin with antibodies attached: molecular design for uranium neutron-capture therapy. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[207] A. Rynda-Apple,et al. Immunopathology and Infectious Diseases Virus-Like Particle-Induced Protection Against MRSA Pneumonia Is Dependent on IL-13 and Enhancement of Phagocyte Function , 2012 .
[208] Nicole F Steinmetz,et al. The art of engineering viral nanoparticles. , 2011, Molecular pharmaceutics.
[209] H. Horinouchi,et al. Structure, photophysical property, and cytotoxicity of human serum albumin complexed with tris(dicarboxymethylene)[60]fullerene. , 2008, Bioconjugate chemistry.
[210] Marianne Manchester,et al. Viruses and their uses in nanotechnology , 2006 .
[211] M G Finn,et al. RNA-directed packaging of enzymes within virus-like particles. , 2010, Angewandte Chemie.
[212] Nicole F Steinmetz,et al. Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing Peptide receptors. , 2011, Small.
[213] V. Kickhoefer,et al. Development of the vault particle as a platform technology. , 2013, ACS nano.
[214] N. Normanno,et al. Epidermal growth factor receptor (EGFR) signaling in cancer. , 2006, Gene.
[215] Yuan Zhang,et al. Development of a microRNA delivery system based on bacteriophage MS2 virus‐like particles , 2012, The FEBS journal.
[216] P. Stockley,et al. MS2 viruslike particles: a robust, semisynthetic targeted drug delivery platform. , 2013, Molecular pharmaceutics.
[217] Min Huang,et al. Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth , 2011, PloS one.
[218] M. Tweedle,et al. Fine-tuning the pH trigger of self-assembly. , 2012, Journal of the American Chemical Society.
[219] H. Munro,et al. Ferritin: structure, biosynthesis, and role in iron metabolism. , 1978, Physiological reviews.
[220] CARBON MONOXIDECO,et al. Carbon monoxide. , 2020, JAMA.
[221] F. Kratz,et al. Engineered drug-protein nanoparticle complexes for folate receptor targeting. , 2014, Biochemical engineering journal.
[222] Bing Xu,et al. Applications of nanomaterials inside cells , 2009 .
[223] John E. Johnson,et al. Structures of the native and swollen forms of cowpea chlorotic mottle virus determined by X-ray crystallography and cryo-electron microscopy. , 1995, Structure.
[224] R. Crichton,et al. The catalytic activity of horse spleen apoferritin. Preliminary kinetic studies and the effect of chemical modification. , 1973, The Biochemical journal.
[225] John E. Johnson,et al. Natural Nanochemical Building Blocks: Icosahedral Virus Particles Organized by Attached Oligonucleotides , 2004 .
[226] Peter G Stockley,et al. Engineering thermal stability in RNA phage capsids via disulphide bonds. , 2005, Journal of nanoscience and nanotechnology.
[227] Jing C. Zhou,et al. Engineering of vault nanocapsules with enzymatic and fluorescent properties. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[228] P. Prevelige,et al. Nanoreactors by programmed enzyme encapsulation inside the capsid of the bacteriophage P22. , 2012, ACS nano.
[229] Derek N. Woolfson,et al. Sticky-end assembly of a designed peptide fiber provides insight into protein fibrillogenesis. , 2000 .
[230] Nicole F Steinmetz,et al. Engineering of Brome mosaic virus for biomedical applications. , 2012, RSC advances.
[231] Donald Hilvert,et al. Efficient in vitro encapsulation of protein cargo by an engineered protein container. , 2012, Journal of the American Chemical Society.
[232] Sierin Lim,et al. Thermostability and molecular encapsulation within an engineered caged protein scaffold , 2008, Biotechnology and bioengineering.
[233] L. Lai,et al. On the mechanism of chaperone activity of the small heat-shock protein of Methanococcus jannaschii , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[234] J. Zhao,et al. Epidermal growth factor-ferritin H-chain protein nanoparticles for tumor active targeting. , 2012, Small.
[235] Andries Zijlstra,et al. Viral nanoparticles as tools for intravital vascular imaging , 2006, Nature Medicine.
[236] Jacob M Hooker,et al. Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system. , 2007, Bioconjugate chemistry.
[237] John E. Johnson,et al. Icosahedral virus particles as addressable nanoscale building blocks. , 2002, Angewandte Chemie.
[238] John E. Johnson,et al. Chemical conjugation of heterologous proteins on the surface of Cowpea mosaic virus. , 2004, Bioconjugate chemistry.
[239] Molly K. Gregas,et al. Apoferritin protein cages: a novel drug nanocarrier for photodynamic therapy. , 2008, Chemical communications.
[240] Silvio Aime,et al. Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging. , 2002, Angewandte Chemie.
[241] Kwangmeyung Kim,et al. Hybrid ferritin nanoparticles as activatable probes for tumor imaging. , 2011, Angewandte Chemie.
[242] Nicole F Steinmetz,et al. Controlled immobilisation of active enzymes on the cowpea mosaic virus capsid. , 2012, Nanoscale.
[243] N. Molino,et al. Caged protein nanoparticles for drug delivery. , 2014, Current opinion in biotechnology.
[244] G J Strous,et al. Endocytosis of GPI-linked membrane folate receptor-alpha , 1996, The Journal of cell biology.
[245] Sebyung Kang,et al. Genetically engineering encapsulin protein cage nanoparticle as a SCC-7 cell targeting optical nanoprobe , 2014, Biomaterials Research.
[246] Alaa A. A. Aljabali,et al. CPMV-DOX delivers. , 2013, Molecular pharmaceutics.
[247] Derek N. Woolfson,et al. Rational design and application of responsive α-helical peptide hydrogels , 2009, Nature materials.
[248] S. Franzen,et al. The Red clover necrotic mosaic virus capsid as a multifunctional cell targeting plant viral nanoparticle. , 2011, Bioconjugate chemistry.